WILEX AG announced that Professor Olaf G. Wilhelm will step down as Chairman of the Executive Management Board when his director's contract expires on 31 March 2014. Dr. Jan Schmidt-Brand, who has been the company's Chief Financial Officer since 2012, will lead the Executive Management Board of WILEX AG effective 1 April 2014. Going forward, he will hold both posts and continue to serve as Managing Director of Heidelberg Pharma GmbH.

Dr. Paul Bevan will remain responsible for the Group's R&D activities and make himself available as the main point of contract for licensing talks in connection with WILEX' projects.